AMBU-B π Ambu - Overview
Exchange: CO • Country: Denmark • Currency: DKK • Type: Common Stock • ISIN: DK0060946788
AMBU-B: Medical Devices, Anaesthesia, Endoscopy, Neurology, Cardiology, Respiratory, Training
Ambu A/S is a medical technology company that has been at the forefront of developing, producing, and selling medical devices to hospitals, clinics, and rescue services worldwide for over eight decades. Founded in 1937, the company has established itself as a leading provider of innovative medical solutions, with a diverse product portfolio that caters to various medical specialties. Its product range includes anaesthesia, patient monitoring and diagnostics products, which are designed to improve patient outcomes and enhance the efficiency of healthcare services.
The company's product offerings also extend to endoscopy, with a range of products such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, and displaying units. These products are designed to facilitate minimally invasive procedures, allowing healthcare professionals to diagnose and treat various medical conditions with greater precision and accuracy. Additionally, Ambu A/S offers neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products, which are used to diagnose and monitor neurological disorders.
Ambu A/S also has a significant presence in the field of cardiology, with a range of products designed to support the diagnosis and treatment of cardiovascular diseases. Its airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators, are used in various medical settings, including operating rooms, intensive care units, and emergency departments. The company's product portfolio is further complemented by extrication collars, resuscitators, video laryngoscopes, and training manikins, which are used for patient simulation and training purposes.
Headquartered in Ballerup, Denmark, Ambu A/S is a publicly traded company, listed under the ISIN code DK0060946788, with its common stock classified under the GICS Sub Industry of Health Care Equipment. With a strong commitment to innovation and customer satisfaction, the company continues to develop and market medical devices that meet the evolving needs of healthcare professionals and patients worldwide. For more information, please visit the company's website at https://www.ambu.com.
Additional Sources for AMBU-B Stock
AMBU-B Stock Overview
Market Cap in USD | 4,221m |
Sector | Healthcare |
Industry | Medical Devices |
GiC Sub-Industry | Health Care Equipment |
IPO / Inception |
AMBU-B Stock Ratings
Growth 5y | -15.3% |
Fundamental | 38.5% |
Dividend | 27.2% |
Rel. Strength Industry | 169 |
Analysts | - |
Fair Price Momentum | 96.28 DKK |
Fair Price DCF | 65.11 DKK |
AMBU-B Dividends
Dividend Yield 12m | 0.36% |
Yield on Cost 5y | 0.34% |
Annual Growth 5y | -8.62% |
Payout Consistency | 82.8% |
AMBU-B Growth Ratios
Growth Correlation 3m | -90.7% |
Growth Correlation 12m | 28.9% |
Growth Correlation 5y | -55.9% |
CAGR 5y | -1.13% |
CAGR/Mean DD 5y | -0.02 |
Sharpe Ratio 12m | 0.15 |
Alpha | -15.98 |
Beta | 0.67 |
Volatility | 43.83% |
Current Volume | 516.5k |
Average Volume 20d | 390.1k |
As of December 21, 2024, the stock is trading at DKK 106.30 with a total of 516,529 shares traded.
Over the past week, the price has changed by -1.76%, over one month by -6.00%, over three months by -19.95% and over the past year by +6.26%.
Partly, yes. Based on ValueRay Fundamental Analyses, Ambu (CO:AMBU-B) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 38.49 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AMBU-B as of December 2024 is 96.28. This means that AMBU-B is currently overvalued and has a potential downside of -9.43%.
Ambu has no consensus analysts rating.
According to ValueRays Forecast Model, AMBU-B Ambu will be worth about 105.9 in December 2025. The stock is currently trading at 106.30. This means that the stock has a potential downside of -0.35%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 127.6 | 20.1% |
Analysts Target Price | - | - |
ValueRay Target Price | 105.9 | -0.3% |